South & Central America Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia,

South & Central America Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)

The South & Central America enteral and parenteral medical nutrition market is expected to grow from US$ 975.68 million in 2023 to US$ 1,377.32 million by 2028. It is estimated to grow at a CAGR of 7.1% from 2023 to 2028.

Rise in Prevalence of Gastrointestinal Diseases Fuels South & Central America Enteral and Parenteral Medical Nutrition Market

Crohn’s disease, bowel obstruction, ulcerative colitis, short bowel syndrome, microscopic colitis, and certain cancers are a few examples of gastrointestinal diseases. Patients with gastrointestinal diseases are at an elevated risk of nutritional deterioration as they are asked to fast before undergoing diagnostic tests. They may also face nutritional deterioration due to therapeutic dietary restriction and loss of appetite caused by anorexia or altered nutritional requirement, which can be a result of the disease itself. Thus, medical nutrition is recommended for gastrointestinal disease patients as these patients cannot ingest food. Thus, the enteral and parenteral routes are preferred to provide them with essential nutrients. Enteral feeding refers to food nutrition intake directly through the mouth or through a tube that passes the digestive tract (mouth to stomach/small intestine and then anus). This type of nutrition is preferred to provide treatment support for patients suffering from chronic ailments, such as neurological disorders, gastrointestinal diseases, and inherited metabolic diseases. Some people may not show compatibility toward tube insertion, which makes meeting their calorie and nutrient needs difficult. In such cases, parenteral nutrition is preferred to ensure their bodies remain hydrated and meet the calorie and other nutrient intake required to maintain physical well-being and function. Parenteral nutrition is indicated when patients cannot meet their nutritional needs due to diseases, such as cancer and chronic diseases affecting the gastrointestinal tract. This type of nutrition is the cornerstone of therapy for most patients with severe SBS. Therefore, the elevating prevalence of gastrointestinal diseases drives the growth of the enteral and parenteral medical nutrition market.

South & Central America Enteral and Parenteral Medical Nutrition Market Overview

The South & Central America enteral and parenteral medical nutrition market is segmented into Brazil, Argentina, Chile, Peru, Colombia, Mexico, and the Rest of South & Central America. South & Central America occupies a significant position in the enteral and parenteral medical nutrition market and is estimated to register a robust growth rate over the forecast period. Factors such as the growing geriatric population, rising incidence of chronic diseases, rising incidence of neurologic disorders such as stroke and cerebral aneurysms, and product innovations by the players operating in the region are driving the market.

South & Central America Enteral and Parenteral Medical Nutrition Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Enteral and Parenteral Medical Nutrition Market Segmentation

The South & Central America enteral and parenteral medical nutrition market is segmented into indication, nutrition type, form, product type, route of administration, age group, and distribution channel, and country.

Based on indication, the South & Central America enteral and parenteral medical nutrition market is segmented into elderly, gastrointestinal disorders, diabetes, cancer, respiratory disorders, alzheimer’s disease, dementia, renal disease, liver failure, post Covid-19, and other indications. The elderly segment held the largest share of the South & Central America enteral and parenteral medical nutrition market in 2023. Gastrointestinal disorders are segmented into IBD, IBS, and others.

Based on nutrition type, the South & Central America enteral and parenteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held a larger share of the South & Central America enteral and parenteral medical nutrition market in 2023.

Based on form, the South & Central America enteral and parenteral medical nutrition market is segmented into liquid, powder, and semi solid. The liquid segment held the largest share of the South & Central America enteral and parenteral medical nutrition market in 2023.

Based on product type, the South & Central America enteral and parenteral medical nutrition market is segmented into general and disease specific. The general segment held the largest share of the South & Central America enteral and parenteral medical nutrition market in 2023.

Based on route of administration, the South & Central America enteral and parenteral medical nutrition market is segmented into oral, tube feed, and parenteral. The parenteral segment held the largest share of the South & Central America enteral and parenteral medical nutrition market in 2023.

Based on age group, the South & Central America enteral and parenteral medical nutrition market is segmented into above 60 years, 18-60 years, 3-18 years, and below 3 years. The above 60 years segment held the largest share of the South & Central America enteral and parenteral medical nutrition market in 2023.

Based on distribution channel, the South & Central America enteral and parenteral medical nutrition market is segmented into a hospital pharmacy, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest share of the South & Central America enteral and parenteral medical nutrition market in 2023.

Based on country, the South & Central America enteral and parenteral medical nutrition market is segmented into Brazil, Argentina, Chile, Peru, Colombia, Mexico, and the Rest of South & Central America. Brazil dominated the share of the South & Central America enteral and parenteral medical nutrition market in 2023.

Abbott Laboratories; B. Braun SE; Baxter International Inc; Fresenius Kabi AG; Nestle SA; and Nutricia International BV are some of the leading companies operating in the South & Central America enteral and parenteral medical nutrition market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America enteral and parenteral medical nutrition market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in South & Central America enteral and parenteral medical nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.